Dapoxetine is a new anti-depressant. Based on two major clinical trials, Dapoxetine, also known by it's brand name Priligy, has been found to be safe and effective for the treatment of premature ejaculation or PE. Dapoxetine is a short acting selective serotonin reuptake inhibitor (SSRI).
SSRIs have previously been known to be used off-label for premature ejaculation.
Dr. Jon Pryor, who is the head researcher at the University of Minnesota, stated that Dapoxetine lengthened the time of ejaculation time as well as gave users more control over ejaculation.
Information from this study can be read on the journal, The Lancet.
A team of researcers examined the results of two clinical trials, involving 2,614 men. The men in the study all suffered from moderate to severe premature ejaculation. These men on average were ejaculating within one minute of penetration. The researchers randomly chose half of the men to receive Dapoxetine while the other half were given a placebo. Both groups of men were required to take their medication from one to three hours before sexual intercourse.
When the study reached 3 months, the men taking a 30 mg dose of dapoxetine took an average 2.78 minutes to ejaculate after penetration. The men on a 60 mg dose took 3.32 minutes. The placebo group averaged 1.75 minutes also after three months.